2024-05-15 |
2024-05-13 |
S
Sale
|
Goette Roland
EVP and President EMEA
Officer
|
1,000
-0.2%
237.90
100,000
USD
|
1,000
-0.2%
|
237.90
|
100,000
USD
|
|
2024-05-15 |
2024-05-13 |
S
Sale
|
Goette Roland
EVP and President EMEA
Officer
|
1,000
-9.7%
237.14
100,000
USD
|
1,000
-9.7%
|
237.14
|
100,000
USD
|
|
2024-05-15 |
2024-05-13 |
S
Sale
|
Goette Roland
EVP and President EMEA
Officer
|
1,000
-9.5%
236.28
100,000
USD
|
1,000
-9.5%
|
236.28
|
100,000
USD
|
|
2024-05-01 |
2024-04-30 |
S
Sale
|
Garrison Michael David
EVP & President Medical
Officer
|
1,715
-24.2%
232.81
399,269
USD
|
1,715
-24.2%
|
232.81
|
399,269
USD
|
|
2024-03-15 |
2024-03-14 |
S
Sale
|
Spoerel Thomas J
SVP,Controller&Chief Acct Off
Officer
|
282
-11.0%
238.29
67,198
USD
|
282
-11.0%
|
238.29
|
67,198
USD
|
|
2023-12-12 |
2023-12-11 |
S
Sale
|
Garrison Michael David
EVP & President Medical
Officer
|
1,239
-14.6%
232.46
288,018
USD
|
1,239
-14.6%
|
232.46
|
288,018
USD
|
|
2023-11-29 |
2023-11-28 |
S
Sale
|
Byrd Richard
EVP & President Interventional
Officer
|
2,156
-34.4%
238.47
514,141
USD
|
2,156
-34.4%
|
238.47
|
514,141
USD
|
|
2023-09-06 |
2023-09-05 |
S
Sale
|
Byrd Richard
EVP & President Interventional
Officer
|
459
-11.8%
274.48
125,986
USD
|
459
-11.8%
|
274.48
|
125,986
USD
|
|
2023-08-30 |
2023-08-28 |
S
Sale
|
Fraser Claire
Non-Executive Director
|
848
-3.8%
281.66
238,848
USD
|
848
-3.8%
|
281.66
|
238,848
USD
|
|
2023-08-14 |
2023-08-11 |
S
Sale
|
Hickey David
EVP & President, Life Sciences
Officer
|
2,974
-41.5%
277.85
826,326
USD
|
2,974
-41.5%
|
277.85
|
826,326
USD
|
|
2023-08-09 |
2023-08-08 |
S
Sale
|
Garrison Michael David
EVP & President Medical
Officer
|
1,300
-20.1%
277.13
360,269
USD
|
1,300
-20.1%
|
277.13
|
360,269
USD
|
|
2023-02-06 |
2023-02-03 |
PS
Planned sale
|
Byrd Richard
EVP & President Interventional
Officer
|
1,421
-25.6%
248.60
353,261
USD
|
1,421
-25.6%
|
248.60
|
353,261
USD
|
|
2022-08-17 |
2022-08-15 |
PS
Planned sale
|
Polen Thomas E Jr
Chairman, CEO and President
Executive Director
|
9,500
-24.8%
265.13
2,518,735
USD
|
9,500
-24.8%
|
265.13
|
2,518,735
USD
|
|
2022-08-17 |
2022-08-15 |
PS
Planned sale
|
Hickey David
EVP & President, Life Sciences
Officer
|
475
-12.5%
265.00
125,875
USD
|
475
-12.5%
|
265.00
|
125,875
USD
|
|
2022-08-11 |
2022-08-09 |
PS
Planned sale
|
Khichi Samrat S.
EVP and General Counsel
Officer
|
9,185
-60.8%
260.44
2,392,141
USD
|
9,185
-60.8%
|
260.44
|
2,392,141
USD
|
|
2022-08-11 |
2022-08-09 |
PS
Planned sale
|
Polen Thomas E Jr
Executive Vice President
Officer
|
1,652
-5.4%
260.00
429,520
USD
|
1,652
-5.4%
|
260.00
|
429,520
USD
|
|
2022-08-11 |
2022-08-08 |
PS
Planned sale
|
Khichi Samrat S.
EVP and General Counsel
Officer
|
7,295
-55.2%
260.44
1,899,910
USD
|
7,295
-55.2%
|
260.44
|
1,899,910
USD
|
|
2022-06-09 |
2022-06-07 |
S
Sale
|
Spoerel Thomas J
VP Controller & Chief Acct Off
Officer
|
443
-29.5%
260.00
115,180
USD
|
443
-29.5%
|
260.00
|
115,180
USD
|
|
2022-05-10 |
2022-05-06 |
S
Sale
|
Hickey David
EVP & President, Life Sciences
Officer
|
475
-11.1%
256.00
121,600
USD
|
475
-11.1%
|
256.00
|
121,600
USD
|
|
2022-02-28 |
2022-02-25 |
S
Sale
|
Larson Betty D
EVP HR & CHRO
Officer
|
601
-9.3%
271.90
163,412
USD
|
601
-9.3%
|
271.90
|
163,412
USD
|
|
2022-02-28 |
2022-02-25 |
S
Sale
|
Larson Betty D
EVP HR & CHRO
Officer
|
203
-3.3%
271.90
55,196
USD
|
203
-3.3%
|
271.90
|
55,196
USD
|
|
2022-02-28 |
2022-02-25 |
S
Sale
|
Larson Betty D
EVP HR & CHRO
Officer
|
284
-4.6%
271.90
77,220
USD
|
284
-4.6%
|
271.90
|
77,220
USD
|
|
2022-02-28 |
2022-02-25 |
S
Sale
|
Larson Betty D
EVP HR & CHRO
Officer
|
744
-11.2%
271.90
202,294
USD
|
744
-11.2%
|
271.90
|
202,294
USD
|
|
2022-02-28 |
2022-02-25 |
S
Sale
|
Larson Betty D
EVP HR & CHRO
Officer
|
2,036
-25.7%
271.90
553,588
USD
|
2,036
-25.7%
|
271.90
|
553,588
USD
|
|
2022-02-28 |
2022-02-25 |
S
Sale
|
Larson Betty D
EVP HR & CHRO
Officer
|
4,442
-43.1%
271.90
1,207,780
USD
|
4,442
-43.1%
|
271.90
|
1,207,780
USD
|
|
2022-02-28 |
2022-02-25 |
S
Sale
|
Larson Betty D
EVP HR & CHRO
Officer
|
3,914
-40.0%
271.90
1,064,217
USD
|
3,914
-40.0%
|
271.90
|
1,064,217
USD
|
|
2022-02-28 |
2022-02-25 |
S
Sale
|
Larson Betty D
EVP HR & CHRO
Officer
|
2,150
-26.8%
271.90
584,585
USD
|
2,150
-26.8%
|
271.90
|
584,585
USD
|
|
2022-02-10 |
2022-02-08 |
S
Sale
|
Fraser Claire
Non-Executive Director
|
841
-3.8%
271.70
228,500
USD
|
841
-3.8%
|
271.70
|
228,500
USD
|
|
2022-02-07 |
2022-02-03 |
PS
Planned sale
|
Conroy Alexandre
EVP of Integrated Supply Chain
Officer
|
6,410
-23.2%
270.16
1,731,726
USD
|
6,410
-23.2%
|
270.16
|
1,731,726
USD
|
|
2021-12-17 |
2021-12-16 |
S
Sale
|
Larson Betty D
EVP HR & CHRO
Officer
|
2,789
-32.2%
255.00
711,195
USD
|
2,789
-32.2%
|
255.00
|
711,195
USD
|
|
2021-12-17 |
2021-12-16 |
S
Sale
|
Larson Betty D
EVP HR & CHRO
Officer
|
552
-6.0%
255.00
140,760
USD
|
552
-6.0%
|
255.00
|
140,760
USD
|
|
2021-12-09 |
2021-12-07 |
S
Sale
|
Spoerel Thomas J
VP Controller & Chief Acct Off
Officer
|
233
-17.8%
250.00
58,250
USD
|
233
-17.8%
|
250.00
|
58,250
USD
|
|
2021-08-09 |
2021-08-06 |
S
Sale
|
Spoerel Thomas J
VP Controller & Chief Acct Off
Officer
|
266
-17.2%
242.30
64,452
USD
|
266
-17.2%
|
242.30
|
64,452
USD
|
|
2021-06-02 |
2021-05-28 |
S
Sale
|
Lim James C
Executive Vice President
Officer
|
3,429
-81.1%
241.68
828,721
USD
|
3,429
-81.1%
|
241.68
|
828,721
USD
|
|
2021-05-28 |
2021-05-27 |
S
Sale
|
Fraser Claire
Non-Executive Director
|
390
-1.9%
241.36
94,130
USD
|
390
-1.9%
|
241.36
|
94,130
USD
|
|
2020-11-24 |
2020-11-23 |
S
Sale
|
Goette Roland
EVP and President, EMEA
Officer
|
930
-10.4%
230.10
213,993
USD
|
930
-10.4%
|
230.10
|
213,993
USD
|
|
2020-07-13 |
2020-07-09 |
PS
Planned sale
|
Kaltenbach Patrick
EVP & Pres Life Sciences
Officer
|
1,272
-11.0%
260.00
330,720
USD
|
1,272
-11.0%
|
260.00
|
330,720
USD
|
|
2020-06-05 |
2020-06-05 |
PS
Planned sale
|
Kaltenbach Patrick
EVP & Pres Life Sciences
Officer
|
1,049
-8.3%
243.20
255,117
USD
|
1,049
-8.3%
|
243.20
|
255,117
USD
|
|
2020-06-02 |
2020-06-02 |
PS
Planned sale
|
Kaltenbach Patrick
EVP & Pres Life Sciences
Officer
|
222
-1.5%
244.83
54,352
USD
|
222
-1.5%
|
244.83
|
54,352
USD
|
|
2020-05-08 |
2020-05-08 |
S
Sale
|
Fraser Claire
Non-Executive Director
|
771
-3.7%
256.56
197,808
USD
|
771
-3.7%
|
256.56
|
197,808
USD
|
|
2020-03-17 |
2020-03-16 |
PS
Planned sale
|
Khichi Samrat S.
EVP and General Counsel
Officer
|
4,349
-45.3%
224.53
976,481
USD
|
4,349
-45.3%
|
224.53
|
976,481
USD
|
|
2020-02-11 |
2020-02-11 |
S
Sale
|
Fraser Claire
Non-Executive Director
|
700
-3.2%
258.70
181,090
USD
|
700
-3.2%
|
258.70
|
181,090
USD
|
|
2020-02-11 |
2020-02-11 |
S
Sale
|
Fraser Claire
Non-Executive Director
|
800
-3.6%
258.73
206,984
USD
|
800
-3.6%
|
258.73
|
206,984
USD
|
|
2020-02-05 |
2020-02-04 |
PS
Planned sale
|
Campion Simon D
EVP and Segment President
Officer
|
1,439
-11.8%
285.09
410,245
USD
|
1,439
-11.8%
|
285.09
|
410,245
USD
|
|
2020-02-05 |
2020-02-04 |
PS
Planned sale
|
Campion Simon D
EVP and Segment President
Officer
|
2,744
-20.3%
285.09
782,287
USD
|
2,744
-20.3%
|
285.09
|
782,287
USD
|
|
2020-02-05 |
2020-02-04 |
PS
Planned sale
|
Campion Simon D
EVP and Segment President
Officer
|
1,896
-15.0%
285.09
540,531
USD
|
1,896
-15.0%
|
285.09
|
540,531
USD
|
|
2020-02-05 |
2020-02-04 |
PS
Planned sale
|
Campion Simon D
EVP and Segment President
Officer
|
1,600
-12.9%
285.09
456,144
USD
|
1,600
-12.9%
|
285.09
|
456,144
USD
|
|
2020-02-05 |
2020-02-04 |
PS
Planned sale
|
Campion Simon D
EVP and Segment President
Officer
|
406
-3.6%
285.09
115,747
USD
|
406
-3.6%
|
285.09
|
115,747
USD
|
|
2020-02-05 |
2020-02-04 |
S
Sale
|
Mas Ribo Alberto
EVP and Pres, Life Sciences
Officer
|
1,430
-14.6%
285.00
407,550
USD
|
1,430
-14.6%
|
285.00
|
407,550
USD
|
|
2020-01-28 |
2020-01-28 |
PS
Planned sale
|
FORLENZA VINCENT A
Chairman, CEO and President
Executive Director
|
28,514
-12.0%
280.96
8,011,293
USD
|
28,514
-12.0%
|
280.96
|
8,011,293
USD
|
|
2020-01-27 |
2020-01-27 |
PS
Planned sale
|
FORLENZA VINCENT A
Chairman, CEO and President
Executive Director
|
25,546
-10.9%
280.09
7,155,179
USD
|
25,546
-10.9%
|
280.09
|
7,155,179
USD
|
|
2020-01-27 |
2020-01-24 |
PS
Planned sale
|
FORLENZA VINCENT A
Chairman, CEO and President
Executive Director
|
7,177
-3.3%
280.13
2,010,493
USD
|
7,177
-3.3%
|
280.13
|
2,010,493
USD
|
|
2020-01-27 |
2020-01-23 |
PS
Planned sale
|
FORLENZA VINCENT A
Chairman, CEO and President
Executive Director
|
6,284
-2.9%
280.06
1,759,897
USD
|
6,284
-2.9%
|
280.06
|
1,759,897
USD
|
|
2020-01-10 |
2020-01-10 |
PS
Planned sale
|
FORLENZA VINCENT A
Chairman, CEO and President
Executive Director
|
19,675
-8.6%
275.15
5,413,576
USD
|
19,675
-8.6%
|
275.15
|
5,413,576
USD
|
|
2020-01-10 |
2020-01-08 |
PS
Planned sale
|
FORLENZA VINCENT A
Chairman, CEO and President
Executive Director
|
13,860
-6.2%
275.19
3,814,133
USD
|
13,860
-6.2%
|
275.19
|
3,814,133
USD
|
|
2020-01-03 |
2020-01-02 |
PS
Planned sale
|
FORLENZA VINCENT A
Chairman, CEO and President
Executive Director
|
33,365
-13.8%
271.28
9,051,257
USD
|
33,365
-13.8%
|
271.28
|
9,051,257
USD
|
|
2019-12-18 |
2019-12-16 |
PS
Planned sale
|
Mas Ribo Alberto
EVP and Pres, Life Sciences
Officer
|
11,860
-54.7%
269.51
3,196,389
USD
|
11,860
-54.7%
|
269.51
|
3,196,389
USD
|
|
2019-12-17 |
2019-12-16 |
S
Sale
|
Polen Thomas E Jr
Executive Vice President
Officer
|
4,432
-20.6%
269.63
1,195,000
USD
|
4,432
-20.6%
|
269.63
|
1,195,000
USD
|
|
2019-12-17 |
2019-12-16 |
S
Sale
|
Polen Thomas E Jr
Executive Vice President
Officer
|
1,954
-10.2%
269.63
526,857
USD
|
1,954
-10.2%
|
269.63
|
526,857
USD
|
|
2019-12-16 |
2019-12-13 |
S
Sale
|
Spoerel Thomas J
VP Controller & Chief Acct Off
Officer
|
506
-32.8%
267.95
135,583
USD
|
506
-32.8%
|
267.95
|
135,583
USD
|
|
2019-12-16 |
2019-12-12 |
S
Sale
|
Kaltenbach Patrick
EVP & Pres Life Sciences
Officer
|
339
-2.2%
263.23
89,235
USD
|
339
-2.2%
|
263.23
|
89,235
USD
|
|
2019-12-16 |
2019-12-12 |
PS
Planned sale
|
FORLENZA VINCENT A
Chairman, CEO and President
Executive Director
|
11,626
-5.3%
265.57
3,087,517
USD
|
11,626
-5.3%
|
265.57
|
3,087,517
USD
|
|
2019-12-06 |
2019-12-06 |
S
Sale
|
Kaltenbach Patrick
EVP & Pres Life Sciences
Officer
|
312
-2.0%
261.51
81,591
USD
|
312
-2.0%
|
261.51
|
81,591
USD
|
|
2019-09-10 |
2019-09-06 |
PS
Planned sale
|
FORLENZA VINCENT A
Chairman, CEO and President
Executive Director
|
11,532
-5.0%
260.38
3,002,702
USD
|
11,532
-5.0%
|
260.38
|
3,002,702
USD
|
|
2019-09-09 |
2019-09-06 |
PS
Planned sale
|
Polen Thomas E Jr
Executive Vice President
|
5,823
-26.1%
260.26
1,515,494
USD
|
5,823
-26.1%
|
260.26
|
1,515,494
USD
|
|
2019-09-09 |
2019-09-06 |
PS
Planned sale
|
Bodner Charles R
SVP Corp Fin Chief Acct Office
|
1,514
-42.6%
260.08
393,761
USD
|
1,514
-42.6%
|
260.08
|
393,761
USD
|
|
2019-09-09 |
2019-09-06 |
S
Sale
|
Lim James C
Executive Vice President
|
9,299
-35.1%
263.53
2,450,565
USD
|
9,299
-35.1%
|
263.53
|
2,450,565
USD
|
|
2019-09-03 |
2019-08-30 |
S
Sale
|
Conroy Alexandre
EVP of Integrated Supply Chain
|
46
-0.3%
256.72
11,809
USD
|
46
-0.3%
|
256.72
|
11,809
USD
|
|
2019-08-29 |
2019-08-29 |
S
Sale
|
Conroy Alexandre
EVP of Integrated Supply Chain
Officer
|
9,829
-37.3%
255.06
2,506,985
USD
|
9,829
-37.3%
|
255.06
|
2,506,985
USD
|
|
2019-08-12 |
2019-08-09 |
S
Sale
|
Lim James C
Executive Vice President
Officer
|
15,879
-48.0%
253.31
4,022,309
USD
|
15,879
-48.0%
|
253.31
|
4,022,309
USD
|
|
2019-08-12 |
2019-08-09 |
S
Sale
|
Lim James C
Executive Vice President
Officer
|
6,009
-25.9%
253.31
1,522,140
USD
|
6,009
-25.9%
|
253.31
|
1,522,140
USD
|
|
2019-08-12 |
2019-08-09 |
S
Sale
|
Lim James C
Executive Vice President
Officer
|
1,991
-10.4%
253.31
504,340
USD
|
1,991
-10.4%
|
253.31
|
504,340
USD
|
|
2019-08-12 |
2019-08-09 |
S
Sale
|
Kaltenbach Patrick
EVP & Pres Life Sciences
Officer
|
127
-0.8%
253.78
32,230
USD
|
127
-0.8%
|
253.78
|
32,230
USD
|
|
2019-08-09 |
2019-08-08 |
S
Sale
|
Goette Roland
EVP and President, EMEA
Officer
|
1,717
-21.6%
249.88
429,044
USD
|
1,717
-21.6%
|
249.88
|
429,044
USD
|
|
2019-08-09 |
2019-08-08 |
S
Sale
|
Kaltenbach Patrick
EVP & Pres Life Sciences
Officer
|
150
-0.9%
246.53
36,980
USD
|
150
-0.9%
|
246.53
|
36,980
USD
|
|